The Therapeutic Drug Monitoring Consumables Market Size is valued at USD 2.20 Bn in 2023 and is predicted to reach USD 4.42 Bn by the year 2031 at an 9.5% CAGR during the forecast period for 2024-2031.
Therapeutic Drug Monitoring (TDM) consumables are essential products used to measure drug concentrations in the blood, ensuring treatments are both safe and effective. These consumables play a critical role in maintaining therapeutic drug levels, particularly for medications with narrow therapeutic indices, variable pharmacokinetics, or critical therapeutic effects. High-quality consumables are vital for obtaining accurate and reliable results, helping optimize drug therapy, reducing adverse effects, and improving treatment outcomes. Well-designed and standardized consumables streamline the TDM process, enhancing efficiency and reducing turnaround times. By carefully selecting and utilizing appropriate TDM consumables, laboratories can deliver precise results, contributing significantly to the effective management of patients undergoing drug therapy.
According to the International Association of Therapeutic Drug Monitoring and Clinical Toxicology, therapeutic drug monitoring (TDM) involves laboratory measurements that, with proper interpretation, directly influence prescribing practices. The growing global demand for hospital and medical care institutions is a major driver of the TDM consumables market. Additionally, the importance of TDM in organ transplant procedures and the increasing preference for precision medicine are accelerating market growth. The demand is further bolstered by the need for precise drug dosing tailored to individual pharmacokinetic and pharmacodynamic profiles, regulatory emphasis on preventing toxicity or underdosing for drugs with narrow therapeutic indices, and the expanding availability of diagnostic services in developing regions. Moreover, a heightened focus on research and development activities related to TDM and the widespread use of drug monitoring tests across various therapeutic fields significantly contribute to the market's expansion.
The Therapeutic Drug Monitoring Consumables market is segmented based on the product, technology, class of drugs, and end user. Based on the product, the market is divided into blood collection tubes, syringes and needles, transfer pipettes, calibration standards and controls, centrifuge tubes, and extraction supplies. Based on the technology, the market is divided into immunoassay consumables, chromatography & mass spectrometry consumables. Based on the class of drugs, the market is divided into antiepileptic drugs (AEDS), antiarrhythmic drugs, immunosuppressant drugs, and other drug classes. Based on the end user, the market is divided into hospital laboratories, commercial & private laboratories, and research and academic institutes.
Based on the product, the market is divided into blood collection tubes, syringes and needles, transfer pipettes, calibration standards and controls, centrifuge tubes, and extraction supplies. Among these, the blood collection tubes segment is expected to have the highest growth rate during the forecast period. Blood collection tubes are widely used for routine TDM in monitoring drugs for various therapeutic areas, including immunosuppressants, antibiotics, antiepileptics, and anticancer drugs. These tubes are designed to preserve sample integrity, ensuring accurate results in techniques such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays. The expansion of healthcare infrastructure in developing regions has boosted the use of blood collection tubes, driven by rising TDM awareness and diagnostic needs. Innovations such as vacuum-based collection systems and additives that prevent sample degradation enhance the efficiency and accuracy of TDM, further driving market growth. Blood collection tubes are universally used in hospitals, diagnostic laboratories, research facilities, and clinics, supporting their dominance in the market.
Based on the technology, the market is divided into immunoassay consumables, chromatography & mass spectrometry consumables. Among these, the immunoassay consumables segment dominates the market. Immunoassays are extensively used for routine drug monitoring due to their simplicity, cost-effectiveness, and rapid turnaround times, making them suitable for clinical and point-of-care applications. Immunoassays are extensively used for routine drug monitoring due to their simplicity, cost-effectiveness, and rapid turnaround times, making them suitable for clinical and point-of-care applications. Immunoassays are widely used for initial drug screening and monitoring across various therapeutic areas, making them indispensable in TDM. Compared to more complex techniques like chromatography-mass spectrometry (LC-MS), immunoassays require less specialized expertise and are more accessible for routine clinical workflows. Innovations in immunoassay technology, such as automated platforms and chemiluminescent immunoassays, enhance accuracy, sensitivity, and reproducibility, driving market growth.
The rising incidence of chronic illnesses like cancer, cardiovascular diseases, epilepsy, and autoimmune disorders in the region drives the need for precise drug monitoring. North America, particularly the United States, boasts advanced healthcare facilities with widespread adoption of TDM practices, ensuring steady demand for consumables. The region has a robust pharmaceutical and biotechnology research landscape, fostering innovation in TDM-related technologies and consumables. The push for personalized treatment approaches has further accelerated the demand for precise drug monitoring tools and consumables.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.20 Bn |
|
Revenue Forecast In 2031 |
USD 4.42 Bn |
|
Growth Rate CAGR |
CAGR of 9.5% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Product, Technology, Class of drugs, and End user |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Abbott Laboratories, Alere, Inc., bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Exagen Inc, F. Hoffmann-La Roche Ltd, Sekisui Medical Co., Ltd, Siemens Healthineers AG, Thermo Fisher Scientific, ALPCO, Beckman Coulter, Inc, Theradiag, Grifols S.A., Ark Diagnostics, Inc., Immundiagnostik Ag, Biotez Berlin Buch Gmbh |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Therapeutic Drug Monitoring Consumables Market Snapshot
Chapter 4. Global Therapeutic Drug Monitoring Consumables Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Therapeutic Drug Monitoring Consumables Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Therapeutic Drug Monitoring Consumables Industry Trends
Chapter 5. Therapeutic Drug Monitoring Consumables Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product:
5.2.1. Blood Collection Tubes
5.2.2. Syringes and Needles
5.2.3. Transfer Pipettes
5.2.4. Calibration Standards and Controls
5.2.5. Centrifuge Tubes
5.2.6. Extraction Supplies
Chapter 6. Therapeutic Drug Monitoring Consumables Market Segmentation 2: By Technology, Estimates & Trend Analysis
6.1. Market Share by Technology, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Technologys:
6.2.1. Immunoassay Consumables
6.2.2. Chromatography & Mass Spectrometry Consumables
Chapter 7. Therapeutic Drug Monitoring Consumables Market Segmentation 3: By Class of Drugs, Estimates & Trend Analysis
7.1. Market Share by Class of Drugs, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Class of Drugss:
7.2.1. Antiepileptic Drugs (AEDs)
7.2.2. Antiarrhythmic Drugs
7.2.3. Immunosuppressant Drugs
7.2.4. Other Drug Classes
Chapter 8. Therapeutic Drug Monitoring Consumables Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-Users:
8.2.1. Hospital Laboratories
8.2.2. Commercial & Private Laboratories
8.2.3. Research and Academic Institutes
Chapter 9. Therapeutic Drug Monitoring Consumables Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Therapeutic Drug Monitoring Consumables Market, Regional Snapshot 2023 & 2031
9.2. North America
9.2.1. North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.2.3. North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.2.4. North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Class of Drugs, 2024-2031
9.2.5. North America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.3. Europe
9.3.1. Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.3.3. Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.3.4. Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Class of Drugs, 2024-2031
9.3.5. Europe Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.4. Asia Pacific
9.4.1. Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.4.3. Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.4.4. Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts By Class of Drugs, 2024-2031
9.4.5. Asia Pacific Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.5. Latin America
9.5.1. Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.5.3. Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.5.4. Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Class of Drugs, 2024-2031
9.5.5. Latin America Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.6. Middle East & Africa
9.6.1. Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.6.3. Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.6.4. Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by Class of Drugs, 2024-2031
9.6.5. Middle East & Africa Therapeutic Drug Monitoring Consumables Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial PerProductance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Alere, Inc.
10.2.3. bioMérieux SA
10.2.4. Bio-Rad Laboratories
10.2.5. Danaher Corporation
10.2.6. Exagen Inc
10.2.7. F. Hoffmann-La Roche Ltd
10.2.8. Sekisui Medical Co., Ltd
10.2.9. Siemens Healthineers AG
10.2.10. Thermo Fisher Scientific
10.2.11. ALPCO
10.2.12. Beckman Coulter, Inc
10.2.13. Theradiag
10.2.14. Grifols S.A.
10.2.15. Ark Diagnostics, Inc.
10.2.16. Immundiagnostik Ag
10.2.17. Biotez Berlin Buch Gmbh
Global Therapeutic Drug Monitoring Consumables Market- By Product
Global Therapeutic Drug Monitoring Consumables Market – By Technology
Global Therapeutic Drug Monitoring Consumables Market – By Class of Drugs
Global Therapeutic Drug Monitoring Consumables Market – By End-User
Global Therapeutic Drug Monitoring Consumables Market – By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
